AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42

Authors: Durst, B Sorg, RV Roder, G Betz, B Beckmann, MW Niederacher, D Bender, HG Dall, P
Citation: B. Durst et al., The influence of hormones on CD44 expression in endometrial and breast carcinomas, ONCOL REP, 8(5), 2001, pp. 987-993

Authors: Beckmann, MW Jap, D Djahansouzi, S Nestle-Kramling, C Kuschel, B Dall, P Brumm, C Bender, HG
Citation: Mw. Beckmann et al., Hormone replacement therapy after treatment of breast cancer: Effects on postmenopausal symptoms, bone mineral density and recurrence rates, ONCOL-BASEL, 60(3), 2001, pp. 199-206

Authors: Muschen, M Re, D Betz, B Moers, C Wolf, J Niederacher, D Diehl, V Beckmann, MW
Citation: M. Muschen et al., Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene, INT J CANC, 92(2), 2001, pp. 309-310

Authors: Flototto, T Djahansouzi, S Glaser, M Hanstein, B Niederacher, D Brumm, C Beckmann, MW
Citation: T. Flototto et al., Hormones and hormone antagonists: Mechanisms of action in carcinogenesis of endometrial and breast cancer, HORMONE MET, 33(8), 2001, pp. 451-457

Authors: Glaeser, M Floetotto, T Hanstein, B Beckmann, MW Niederacher, D
Citation: M. Glaeser et al., Gene amplification and expression of the steroid receptor coactivator SRC3(AIB1) in sporadic breast and endometrial carcinomas, HORMONE MET, 33(3), 2001, pp. 121-126

Authors: Brumm, C Beckmann, A Jap, D Oppelt, PG Beckmann, MW
Citation: C. Brumm et al., Diagnosis-related groups in obstetrics and gynecology, GEBURTSH FR, 61(7), 2001, pp. 470-475

Authors: Oppelt, PG Beckmann, MW
Citation: Pg. Oppelt et Mw. Beckmann, Risk factors and risk assessment in menopause, GEBURTSH FR, 61(5), 2001, pp. 257-267

Authors: Kuschel, B Lux, MP Goecke, TO Beckmann, MW
Citation: B. Kuschel et al., Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer, EUR J CAN P, 9(3), 2000, pp. 139-150

Authors: Muschen, M Warskulat, U Beckmann, MW
Citation: M. Muschen et al., Defining CD95 as a tumor suppressor gene, J MOL MED-J, 78(6), 2000, pp. 312-325

Authors: Giagounidis, AAN Beckmann, MW Giagounidis, AS Aivado, M Emde, T Germing, U Riehs, T Heyll, A Aul, C
Citation: Aan. Giagounidis et al., Acute promyelocytic leukemia and pregnancy, EUR J HAEMA, 64(4), 2000, pp. 267-271

Authors: Klein, RM Vester, EG Brehm, MU Dees, H Picard, F Niederacher, D Beckmann, MW Strauer, BE
Citation: Rm. Klein et al., Inflammation of the myocardium as a trigger for arrhythmias, Z KARDIOL, 89, 2000, pp. 24-35

Authors: Kuschel, B Kochli, OR Niederacher, D Muller, H Beckmann, MW
Citation: B. Kuschel et al., Inherited cancer syndromes in gynaecology: what the practitioner needs to know!, SCHW MED WO, 130(10), 2000, pp. 362-375

Authors: Gerhardt, A Scharf, RE Beckmann, MW Struve, S Bender, HG Pillny, M Sandmann, W Zotz, RB
Citation: A. Gerhardt et al., Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium., N ENG J MED, 342(6), 2000, pp. 374-380

Authors: Muschen, M Beckmann, MW
Citation: M. Muschen et Mw. Beckmann, CD95 ligand expression as a criterion of malignant transformation in breast cancer, J PATHOLOGY, 191(4), 2000, pp. 468-469

Authors: Muschen, M Moers, C Warskulat, U Even, J Niederacher, D Beckmann, MW
Citation: M. Muschen et al., CD95 ligand expression as a mechanism of immune escape in breast cancer, IMMUNOLOGY, 99(1), 2000, pp. 69-77

Authors: Bender, HG Beckmann, MW
Citation: Hg. Bender et Mw. Beckmann, Diagnosis and therapy of uterine bleeding, GYNAKOLOGE, 33(9), 2000, pp. 633-633

Authors: Jap, D Lampe, B Beckmann, MW
Citation: D. Jap et al., Diagnosis and treatment of tumor-associated acute vaginal and uterine bleeding, GYNAKOLOGE, 33(9), 2000, pp. 659-664

Authors: Beckmann, MW Werner, Y Renner, SP Fasching, PA Jap, D Kuschel, B
Citation: Mw. Beckmann et al., Cancer detection in gynecology, GYNAKOLOGE, 33(7), 2000, pp. 474-481

Authors: Dall, P Bauerschmitz, GJ Neufeind, P Beckmann, MW
Citation: P. Dall et al., Pain therapy in clinical practice, GYNAKOLOGE, 33(7), 2000, pp. 483-488

Authors: Beckmann, MW Lorenz, C Dall, P
Citation: Mw. Beckmann et al., Placement and care of venous indwelling catheters and portosystems, GYNAKOLOGE, 33(4), 2000, pp. 255-260

Authors: Beckmann, MW Hanstein, B Niederacher, D Jap, D Kuschel, B Bender, HG
Citation: Mw. Beckmann et al., Mechanisms of ovarian steroid hormones and antioestrogens in the development of carcinomas of the breast and endometrium, GEBURTSH FR, 60(2), 2000, pp. 71-76

Authors: Beckmann, MW Jap, D Kuschel, B Dall, P Lux, MP Hanstein, B Bender, HG
Citation: Mw. Beckmann et al., Ovarian steroid hormones and anti-estrogens: Risks for and prevention of cancers of the breast and endometrium in the menopause, GEBURTSH FR, 60(2), 2000, pp. 77

Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212

Authors: Schmutzler, RK Kempe, A Kiechle, M Beckmann, MW
Citation: Rk. Schmutzler et al., Clinical counselling and care of women with a genetic risk of ovarian and breast cancer, DEUT MED WO, 124(18), 1999, pp. 563-566

Authors: Laake, K Launonen, V Niederacher, D Gudlaugsdottir, S Seitz, S Rio, P Champeme, MH Bieche, I Birnbaum, D White, G Sztan, M Sever, N Plummer, S Osorio, A Broeks, A Huusko, P Spurr, N Borg, A Cleton-Jansen, AM van't Veer, L Benitez, J Casey, G Peterlin, B Olah, E Varley, J Bignon, YJ Scherneck, S Sigurdardottir, V Lidereau, R Eyfjord, J Beckmann, MW Winqvist, R Skovlund, E Borresen-Dale, AL
Citation: K. Laake et al., Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study, GENE CHROM, 25(3), 1999, pp. 212-221
Risultati: 1-25 | 26-42